Analysis for loss of heterozygosity on chromosome arm 13q by STR analysis or SNP sequencing can replace analysis ofFLT3-ITD to detect patients with prognostically adverse AML
- 3 September 2014
- journal article
- research article
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 53 (12) , 1008-1017
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Noninvasive Whole-Genome Sequencing of a Human FetusScience Translational Medicine, 2012
- Impact of FLT3 Internal Tandem Duplication on the Outcome of Related and Unrelated Hematopoietic Transplantation for Adult Acute Myeloid Leukemia in First Remission: A Retrospective AnalysisJournal of Clinical Oncology, 2012
- Insertion of FLT3 internal tandem duplication in the tyrosine kinase domain-1 is associated with resistance to chemotherapy and inferior outcomeBlood, 2009
- A novel molecular mechanism of primary resistance to FLT3-kinase inhibitors in AMLBlood, 2009
- Age-Related Risk Profile and Chemotherapy Dose Response in Acute Myeloid Leukemia: A Study by the German Acute Myeloid Leukemia Cooperative GroupJournal of Clinical Oncology, 2009
- The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemiaBlood, 2008
- Acquired Isodisomy for chromosome 13 is common in AML, and associated with FLT3-itd mutationsLeukemia, 2005
- Atlas der klinischen Hämatologie2004
- Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid LeukemiaJournal of Clinical Oncology, 2003
- Proposed Revised Criteria for the Classification of Acute Myeloid LeukemiaAnnals of Internal Medicine, 1985